ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

DCT Board Approves Drug Development Recompetition

November 30, 1990

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014